To determine whether the somatostatin receptor 2 (sst 2 ) influences angiogenesis and its associated factors in a model of hypoxia-induced retinal neovascularization. METHODS. sst 1 -knockout (KO) mice, in which sst 2 is overexpressed and overfunctional, and sst 2 -KO mice were used. Angiogenesis was evaluated in fluorescein-perfused retinas. Angiogenesis-associated factors were determined by RT-PCR and immunohistochemistry. RESULTS. Retinal neovascularization was increased in sst 2 -KO mice, but remained unchanged in sst 1 -KO compared with wild-type (WT) mice. Retinal levels of sst 2 mRNA were not affected by hypoxia. Normoxic levels of angiogenesis regulators were similar in WT and KO retinas except for mRNA levels of IGF-1, Ang-2, and its receptor Tie-2. In WT, hypoxia induced an increase in mRNA levels of (1) VEGF and its receptors, (2) IGF-1R, and (3) Ang-2 and Tie-2. The increase in VEGF and IGF-1R mRNAs was more pronounced after sst 2 loss, but was less pronounced when sst 2 was overexpressed. In addition, in hypoxic retinas, sst 2 loss increased IGF-1 mRNA, whereas it decreased Ang-1, Tie-1, and Tie-2 mRNA levels. Moreover, Tie-1 mRNA increased when sst 2 was overexpressed. Immunohistochemistry confirmed the results in hypoxic retinas on increased expression of VEGF, IGF-1, and their receptors after sst 2 loss. It also allowed the localization of these factors to specific retinal cells. In this respect, VEGFR-2, IGF-1, and IGF-1R were localized to Müller cells. CONCLUSIONS. These results suggest that sst 2 may be protective against angiogenesis. The immediate clinical importance lies in the establishment of a potential pharmacological target based on sst 2 pharmacology. (Invest Ophthalmol Vis Sci.
T he abnormal formation of new blood vessels characterizes a variety of retinal diseases, including diabetic retinopathy, 1 and requires the involvement of vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF)-1, and their receptors VEGFR-1, VEGFR-2, and IGF-1R. Although the available information on their expression in the retina is far from being exhaustive, these factors have been localized to both retinal cells and microvascular endothelium. [2] [3] [4] [5] [6] Retinal neoangiogenesis is always associated with an increase of VEGF and its receptors 2,3,7 but not of IGF-1. 8 -10 Of the other downstream factors affecting blood vessel growth, recent results indicate that Ang-1 and -2 and their tyrosine kinase receptor Tie-2 are regulated by hypoxia and play a role in retinal neovascularization.
11,12 Although a ligand for Tie-1 has not been found, it has recently been demonstrated that Ang-1 can induce Tie-1 phosphorylation.
13
The potential antiangiogenic role of the peptide somatostatin-14 (SRIF) and its analogues has received much attention, 14 and it involves partial correction of systemic growth hormone dysregulation or inhibition of angiogenesis-associated factors.
15-17 Of the five SRIF receptors mediating SRIF actions, sst 2 is a likely candidate to mediate the angioinhibitory activity of SRIF. Indeed, analogues with high affinity for sst 2 , such as octreotide and BIM23027, counteract the growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia.
18 They are powerful inhibitors of neovascularization in models of proliferative retinopathies. 15, 19 In addition, octreotide inhibits the IGF-1-mediated induction of VEGF in human retinal pigment epithelial (RPE) cells. 16 Moreover, octreotide retards retinopathy progression in diabetic patients in whom photocoagulation has failed. 20 However, despite the growing use of sst 2 agonists as antiangiogenic agents, the mechanisms by which these peptides inhibit the growth of new vessels has not been fully delineated.
Both sst 1 -and sst 2 -knockout (KO) mice have been generated. 21, 22 In their retinas, we have found that sst 1 loss causes an increased expression and function of sst 2 .
23-28
In the present study, retinas of sst 1 -and sst 2 -KO mice were rendered hypoxic and were used to investigate whether altered levels of sst 2 play a role in regulating retinal angiogenesis and its associated factors. Our hypothesis was that, compared with wild-type (WT) retinas, the lack of sst 2 is associated with heavier effects of hypoxia, whereas a chronic overexpression of sst 2 (as in sst 1 -KO retinas) should attenuate these effects.
METHODS

Animals
Experiments were performed on 128 mice of WT (C57BL/6) and sst 1 -or sst 2 -KO strains of both sexes at postnatal day (PD)17 (6 g body weight). In some experiments designed to evaluate development of retinal vasculature, five PD12 mice for each strain were also used. sst 1 -and sst 2 -KO mice were generated as previously reported. 21, 22 Experiments were performed in agreement with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and in compliance with the Italian law on animal care 116/1992 and EEC/609/86. All efforts were made to reduce the number of animals used.
